PI3K / AKT / GSK-3β Pathway Mediates the Ameliorative Effect of Amentoflavone on Hepatorenal Injury Induced by Doxorubicin
(2024). PI3K / AKT / GSK-3β Pathway Mediates the Ameliorative Effect of Amentoflavone on Hepatorenal Injury Induced by Doxorubicin. EKB Journal Management System, 97(1), 3688-3693. doi: 10.21608/ejhm.2024.387337
. "PI3K / AKT / GSK-3β Pathway Mediates the Ameliorative Effect of Amentoflavone on Hepatorenal Injury Induced by Doxorubicin". EKB Journal Management System, 97, 1, 2024, 3688-3693. doi: 10.21608/ejhm.2024.387337
(2024). 'PI3K / AKT / GSK-3β Pathway Mediates the Ameliorative Effect of Amentoflavone on Hepatorenal Injury Induced by Doxorubicin', EKB Journal Management System, 97(1), pp. 3688-3693. doi: 10.21608/ejhm.2024.387337
PI3K / AKT / GSK-3β Pathway Mediates the Ameliorative Effect of Amentoflavone on Hepatorenal Injury Induced by Doxorubicin. EKB Journal Management System, 2024; 97(1): 3688-3693. doi: 10.21608/ejhm.2024.387337